Selected Work

Engagements where the market chose.

A selection of commercial strategy work across pharma, FMCG, and B2B technology in the GCC, MEA, and Latin America. Client names are anonymized where confidentiality applies. Outcomes are real and measured.

Industry
Region
3 results
+38%
category share gain
Pharmaceuticals·GCC·2024

Scaling a Top-3 Pain Brand Across 4 GCC Markets

Repositioning a mature pain franchise to capture +38% category share in Saudi Arabia, UAE, Kuwait, and Qatar.

Read case →
$12M
year-one revenue
FMCG·East Africa·2023

Market Entry for a European FMCG Group in East Africa

Designing the go-to-market for a personal care portfolio entering Kenya, Tanzania, and Uganda from scratch.

Read case →
3.4×
average deal size
B2B Technology·MEA·2025

Repositioning a B2B Health-Tech for Series B

Sharpening positioning, pricing, and commercial narrative ahead of a Series B raise.

Read case →

Could your next engagement be on this page?

Most of the work starts with a 30-minute diagnostic conversation. No pitch.

Book a Strategy Diagnostic